The Extended Wear Sensor Study

This Study is investigating the benefits of the Medtronic Extended Life Glucose Sensor over a 16 day period.

Limited sensor life is a burden many people living with Diabetes have come to expect, we’re looking to change that.

Continuous Glucose Monitoring (CGM) systems have been commercially
available for several years and have been of benefit in patients with Diabetes.
However, many commercially available sensors provide added burden to the
lives of people with diabetes, requiring multiple calibrations, separate
transmitters and sensors, and may be limited to a sensor-life of only 7 days.

While there have been recent advances in CGM technology, further improvements relating to sensor accuracy, reliability, reduced number of blood glucose calibrations, and comfort during sensor insertion and wear are required.
The Medtronic Extended Life Glucose Sensor is a single-use integrated disposable device, integrating the sensor and transmitter, requiring no calibrations and with a sensor-life of up to 17 days.

The Diabetes Technology Research Group based out of St Vincent’s Hospital Melbourne are seeking to collect performance data on the Medtronic Extended Life Sensor.

This study is recruiting people with Type 1 Diabetes for a study duration of approximately 18 days, including 6 in-patient visits to St Vincent’s Hospital Melbourne during that time, including four day-long meal tests each lasting 6-7 hours on site.

Become a participant!

Participants will need:
– To be over 18 years of age
– Currently be living with Type 1 Diabetes, managed via insulin
– Be familiar with sensors use
– Be willing to comply with the requirements of the study
– To use a paper glucose monitoring diary provided by the study team
– Be willing to record up to 8 fingerpricks daily.

The 6 study visits include:
A screening visit (~1 hr)
4 X Meal tests (each lasting between 6-7 hours)
And an End of Study Visit (~10 minutes)

Exclusion criteria
– Those who are pregnant or seeking to become pregnant
– Those who have a known allergy to glucocorticoid steroids
– Those will either a skin condition at sensor location or those with an intolerance for sensor tape
– Anyone with an episode of severe hypoglycaemia or DKA within the last 3 months
– Anyone with a major life-threatening disease or psychiatric illnesses

Participants who complete the study procedures will be compensated for their time.

Get involved

Please contact the Research Group Leader to discuss your options.